VN February 2022

Vetnews | February 2022 37 Regulars I Zoetis Livestock Column allergy testing so, you know, if you’re going to plan for a referral, that’s a great way to go. 8 It’s meant for dogs of at least 12 months of age and is suitable for short-term or long-term use. 4,6 If clients are happy with once-daily Apoquel, you can use this chronically to manage the dog’s disease. 2 Cytopoint is an excellent choice for dogs who are difficult to pill, or maybe the owner has trouble with compliance. 4 Cytopoint is great for dogs with severe comorbidities like infections, e.g. bacterial pneumonia and fungal disease. 4,6 Cytopoint can be ideal for owners seeking non-drug therapies because it’s a biological immunotherapy and not a drug. 6 It can be used in dogs of any age, including those under 12 months of age. 4 So, it’s ideal for the long- term treatment of dogs with atopic skin disease. 6 v References: 1. Gonzales AJ, Bowman J, Fici G, et al . Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Journal of Veterinary Pharmacology and Therapeutics 2014;37(4):317-324. doi:10.1111/ jvp.12101. 2. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. VetDermatol . 2015;26(3):171-179. doi:10.1111/vde.12194. 3. Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j.1365-3164.2012.01098. 4. Volume 6C. Summary of the product characteristics SPC-Pharmaceutical, July 2006, revision 2. European Commission, Brussels 5. Olivry T, Mueller RS, Prélaud P, et al . Critically appraised topic on adverse food reactions of companion animals (1): duration of elimination diets. BMC Vet Res . 2015;11:225. doi:10.1186/s12917-015-0541 6. Michels GMet al. Ablinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31monoclonal antibody in client-owned dogs with atopic dermatitis. VetDermatol 2016;27:505-e136. 7. Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia .VetDermatol . 2014 Dec;25(6):512–e86 8. Aleo MM, Galvan EA, Fleck TJ, HumphreyWR, Coscarelli EM, Mahabir SP, McCall RB, Gonzales A. Effects of oclacitinib and prednisolone on skin test sensitivity (abstract). VetDermatol. 2012Jul;23(Suppl. 1):2-104. 9. www.ScienceofStrongerBonds.comResources S4 Apoquel 3,6 mg (film-coated tablets). Reg. No.: 16/21/05. Each film-coated tablet contains 3,6 mg oclacitinib. S4 Apoquel 5,4 mg (film-coated tablets). Reg. No.: 16/21/06. Each film-coated tablet contains 5,4mg oclacitinib. S4 Apoquel 16mg (film- coated tablets). Reg. No.: 16/21/07. Each film-coated tablet contains 16mg oclacitinib. Apoquel is a registered trademark of Zoetis. S4 Cytopoint 10 mg (Injection). Reg. No.: 17/24.5/15.Eachvialof1mlcontains10mglokivetmab.S4Cytopoint20mg(Injection). Reg. No.: 17/24.5/16. Each vial of 1 ml contains 20 mg lokivetmab. S4 Cytopoint 30 mg (Injection). Reg. No.: 17/24.5/17. Each vial of 1 ml contains 30 mg lokivetmab. S4 Cytopoint 40 mg (Injection). Reg. No.: 17/24.5/18. Each vial of 1 ml contains 40 mg lokivetmab. Cytopoint is a registered trademark of Zoetis. S4 Convenia (powder for injection). Reg. No.: 07/17.1.1.2/08. Each ml of the reconstituted solution contains 80 mg cefovecin with methylparaben 1,8 mg, propylparaben 0,2 mg and benzyl alcohol 12,3 mg as preservatives. Diluent for Convenia. Reg. No.: 07/34/09. Each vial of diluent contains water for injections and benzyl alcohol 1,3 % as preservative. Convenia is a registered trademark of Zoetis. For full prescribing information refer to the package insert approved by theMedicines Regulatory Authority. Full product information available fromZoetis South Africa (Pty) Ltd., Co. Reg. No.: 2012/001825/07, 6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196. PostNet Suite 53, Private Bag 9976, Sandton, 2146, South Africa. Tel.: +27 11 245 3300 or 0860 ZOETIS (0860 963847). www.zoetis.co.za CA/LlR/26/22/01 APOQUEL AND CYTOPOINT COMPARISON

RkJQdWJsaXNoZXIy OTc5MDU=